April 13, 2017 / 11:18 AM / in 7 months

BRIEF-Medicenna treats first patient in phase 2b recurrent glioblastoma trial

April 13 (Reuters) - Medicenna Therapeutics Corp:

* Medicenna treats first patient in phase 2b recurrent glioblastoma trial

* Medicenna Therapeutics Corp - patient enrolment is expected to be completed before end of 2017

* Medicenna Therapeutics Corp - top-line results anticipated in first half of 2018

* Medicenna Therapeutics Corp - study will be conducted in approximately ten sites in united states Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below